Quarterly report [Sections 13 or 15(d)]

SEGMENT INFORMATION

v3.25.2
SEGMENT INFORMATION
6 Months Ended
Jun. 30, 2025
SEGMENT INFORMATION  
SEGMENT INFORMATION

13.Segment Information

We view our operations and manage our business as one operating segment, and our chief operating decision maker (CODM) is our chief executive officer. The following table presents segment information for the periods presented:

Three Months Ended June 30, 

Six Months Ended June 30, 

2025

2024

 

2025

2024

(in thousands)

(in thousands)

Total Revenues

$

101,685

$

36,841

$

155,018

$

66,375

Less:

Employee related expenses

18,581

17,080

38,119

36,447

Commercial related expenses

7,273

7,126

12,612

12,260

Outside clinical trial related expenses

3,232

2,368

7,603

4,880

Cost of product sales

4,504

2,807

8,913

4,832

Consultants and third-party services

3,209

4,033

6,618

8,375

Other segment items

3,783

2,980

7,277

6,100

Interest expense, net

1,121

1,477

2,383

2,758

Provision for income taxes

369

434

Segment income (loss)

$

59,613

$

(1,030)

$

71,059

$

(9,277)

There is no reconciling items or adjustments between segment income (loss) presented above and net income (loss) as presented in our statements of operations. The CODM does not review assets in evaluating the segment results and therefore such information is not presented.

For details of revenues disaggregated by category, see “Note 3 – Revenues.”

Employee related expenses primarily comprised salaries, employee benefits, other employee related expenses and stock-based compensation expense. For details of stock-based compensation expense, see “Note 6 – Stock-Based Compensation.” Other segment items for the periods presented primarily comprised travel related expenses, business insurance, taxes and licenses, and facility related expenses.